Analyst Reco. Cerence Inc.

Stocks

CRNC

US1567271093

Software

Real-time Estimate Cboe BZX Other stock markets 01:45:41 08/07/2026 HKT			5-day change	1st Jan Change
10.54 ^USD	-4.05%		-7.42%	-1.96%

11:31pm	SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout \| Stock Movers	MT
07-03	Cerence Inc. Announces Resignation of Marcy Klevorn from Board and Committees, Effective July 1, 2026	CI

Analyst Reco.

04-02	Cantor Fitzgerald Initiates Cerence at Overweight With $11 Price Target	MT
07/08/25	Cerence Q3 revenue beats expectations	RE
22/01/25	Needham Upgrades Cerence to Buy From Hold, $16 Price Target	MT
15/07/24	Evercore ISI Adjusts Cerence's Price Target to $5 From $8, Maintains In Line Rating	MT
13/07/24	Baird Adjusts Price Target on Cerence to $6 From $8, Maintains Neutral Rating	MT
11/05/24	Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating	MT
10/05/24	Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating	MT
10/05/24	Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50	MT
17/04/24	Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating	MT
08/02/24	Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating	MT
08/02/24	Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22	MT
30/11/23	Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating	MT
29/11/23	Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept	MT
28/11/23	Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating	MT
28/11/23	Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating	MT
28/11/23	Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating	MT
09/08/23	Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating	MT
11/05/23	Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating	MT
10/05/23	Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating	MT
10/02/23	Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating	MT
10/02/23	Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating	MT
09/02/23	Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating	MT
09/02/23	Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating	MT
09/02/23	Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating	MT
09/02/23	Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40	MT